侯和磊 - Qingdao Municipal Hospital, Qingdao University

基本信息

浏览量：41

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 110 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Multi-omics Analysis of the Dynamic Role of STAR+ Cells in Regulating Platinum-Based Chemotherapy Responses and Tumor Microenvironment in Serous Ovarian Carcinoma

Hongwei Lan,Weihua Yan, Xiao Huang, Jiali Cui,Helei Hou

Frontiers in pharmacology（2025）

引用0浏览0WOS引用

ARID1A Deficiency Attenuates the Response to EGFR-TKI Treatment in Lung Adenocarcinoma

Fangfang Yang,Helei Hou, Guanqun Wang, Guangming Fu, Xingfa Huo, Xueqin Duan,Na Zhou,Xiaochun Zhang

Frontiers in pharmacology (2025): 1582005-1582005

引用0浏览0WOS引用

Combination of Anlotinib with Immunotherapy Enhanced Both Anti-Angiogenesis and Immune Response in High-Grade Serous Ovarian Cancer

Hongwei Lan,Hui Liu,Helei Hou,Chuantao Zhang,Jingjuan Zhu,Na Zhou,Xiaochun Zhang

Frontiers in immunology (2025): 1539616-1539616

引用0浏览0WOS引用

A Cohort-Based Multi-Omics Identifies Nuclear Translocation of Eif5b /PD-L1/CD44 Complex As the Target to Overcome Osimertinib Resistance of ARID1A-deficient Lung Adenocarcinoma

Dantong Sun,Helei Hou,Feiyue Feng, Weizheng Wu, Jingyu Tan,Tongji Xie, Jiayu Liu, Jinsong Wang,Haili Qian,Junling Li,Puyuan Xing

Experimental Hematology & Oncology（2025）

引用0浏览0WOS引用

Combination Therapy with Chicoric Acid and PD-1/PD-L1 Blockade Improves the Immunotherapy Response in Patient-Derived Ovarian Cancer Xenograft Model

Hongwei Lan,Jingjuan Zhu,Helei Hou,Chuantao Zhang, Xingfa Huo, Yuming Zhang,Fangfang Yang,Na Zhou,Xiaochun Zhang

Cell Communication and Signalingno. 1 (2025): 1-22

引用0浏览0WOS引用

Yuming Zhang,Helei Hou,Xuchen Zhang,Hongwei Lan,Xingfa Huo, Xueqin Duan, Yufeng Li,Xiaochun Zhang,Na Zhou

Digestive Diseases and Sciencespp.1-23, (2024)

引用0浏览0WOS引用

RNF43 in Cancer: Molecular Understanding and Clinical Significance in Immunotherapy

Xingfa Huo,Weizhong Han, Zhen Yang, Yongzhi Lu,Ning Liu,Helei Hou

The journal of gene medicineno. 8 (2024): e3729-e3729

引用0浏览0WOS引用

Conversion Therapy with Chemoimmunotherapy Induced Pcr in a Stage IV Lung Squamous Cell Carcinoma Patient Harboring EGFR Exon 20 Insertion

Mingjin Xu,Xingfa Huo,Chuantao Zhang,Xuchen Zhang,Huiyun Wang, Hongmin Yang, Nan Ge,Yongjie Wang,Helei Hou

HUMAN VACCINES & IMMUNOTHERAPEUTICSno. 1 (2024)

引用0浏览0WOS引用

SMARCA4 Mutations and Expression in Lung Adenocarcinoma: Prognostic Significance and Impact on the Immunotherapy Response

Yuming Zhang,Dantong Sun,Weizhong Han, Zhen Yang, Yongzhi Lu,Xuchen Zhang,Yongjie Wang,Chuantao Zhang,Ning Liu,Helei Hou

FEBS OPEN BIOno. 12 (2024): 2086-2103

引用0浏览0WOS引用

MET Fusions Are Targetable Genomic Variants in the Treatment of Advanced Malignancies

Dantong Sun,Xiaoming Xing,Yongjie Wang,Helei Hou

Cell Communication and Signalingno. 1 (2024)

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Helei Hou(侯和磊)

论文共 110 篇作者统计合作学者相似作者